Literature DB >> 2550123

Expression of ras oncogene p21 protein in early gastric carcinoma and adjacent gastric epithelia.

B Czerniak1, F Herz, W Gorczyca, L G Koss.   

Abstract

The expression of the ras gene product p21 in normal gastric mucosa, early gastric carcinoma of diffuse (gastric) and intestinal types, and in adjacent mucosal abnormalities is reported. The analysis was performed on paraffin sections by an immunohistochemical assay using the mouse monoclonal antibody RAP-5 and the rat monoclonal antibody Y13-259. Expression of ras p21 was assessed by staining intensity and percentage of positively stained cells. In comparison to normal gastric mucosa of non-cancer patients, p21 was overexpressed in nearly all early carcinomas of both types and in the dysplastic and/or metaplastic mucosal alterations accompanying intestinal type of gastric cancer. Increased p21 expression was also observed in the normal-appearing mucosa adjacent to early carcinomas of diffuse type, but not in the morphologically normal gastric epithelium adjacent to the intestinal type. The results of this investigation suggest that ras p21 overexpression may be related to early events of human gastric carcinogenesis. The study supports the notion of different pathways in the development of diffuse (gastric) and intestinal types of gastric carcinomas.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550123     DOI: 10.1002/1097-0142(19891001)64:7<1467::aid-cncr2820640718>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Epithelial proliferation and ras p21 oncoprotein expression in rectal mucosa of patients with ulcerative colitis.

Authors:  E Ierardi; M Principi; R Francavilla; S Passaro; F Noviello; O Burattini; A Francavilla
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

2.  The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions.

Authors:  N R Soman; P Correa; B A Ruiz; G N Wogan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 3.  Molecular biology and gastric carcinoma.

Authors:  P A Wright; G T Williams
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

4.  Characterization of oncogene suppressor marker expression in patients with submucosal gastric carcinoma.

Authors:  Roberson A Moron; Carlos Eduardo Jacob; Claudio José Caldas Bresciani; Kleber Simões; Venâncio Avancini Ferreira Alves; Kyoshi Irya; Joaquim Gama-Rodrigues; Ivan Cecconello; Adhemar Longatto-Filho; Bruno Zilberstein
Journal:  Mol Clin Oncol       Date:  2017-12-29

5.  Molecular assessment of c-H-ras p21 expression in Helicobacter pylori-mediated gastric carcinogenesis.

Authors:  Chandrabose Sureka; Thiyagarajan Ramesh
Journal:  Mol Cell Biochem       Date:  2011-11-02       Impact factor: 3.396

6.  Helicobacter pylori infection and oncogene expressions in gastric carcinoma and its precursor lesions.

Authors:  Jie Wang; David S Chi; George B Kalin; Christina Sosinski; Lou Ellen Miller; Izabela Burja; Eapen Thomas
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

7.  Absence of ras gene mutations in early gastric carcinomas.

Authors:  M E Craanen; P Blok; B Top; L Boerrigter; W Dekker; G J Offerhaus; G N Tytgat; S Rodenhuis
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

8.  Multiple simultaneous gastric carcinomas.

Authors:  C Wittekind; M Klimpfinger; P Hermanek; A Tannapfel
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Expression of nuclear retinoid receptors in normal, premalignant and malignant gastric tissues determined by in situ hybridization.

Authors:  S Y Jiang; S R Shen; R Y Shyu; J C Yu; H J Harn; M Y Yeh; M M Lee; Y C Chang
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

10.  Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis.

Authors:  A Takeno; I Takemasa; Y Doki; M Yamasaki; H Miyata; S Takiguchi; Y Fujiwara; K Matsubara; M Monden
Journal:  Br J Cancer       Date:  2008-09-30       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.